Almost 50% of ER/PR+ BC tumors are also positive for Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2), commonly referred to as HER2/NEU (human epidermal growth factor receptor 2) (6). The gene discussed is ERBB2; the disease is breast cancer.